Successful rechallenge with reduced dose of erlotinib in a patient with lung adenocarcinoma who developed erlotinibassociated leukocytoclastic vasculitis: A case report

Author： Su Bo-An   Shen Wan-Lin   Chang Sheng-Tsung   Feng Li-Yia   Wu Chia-Jung   Feng Yin-Hsun  

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.3, Iss.6, 2012-06, pp. : 1280-1282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report

By                  

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1537-1540

Spandidos Publications

Access to resources Recommend Favorite

Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: A case report

By              

Experimental and Therapeutic Medicine, Vol. 10, Iss. 1, 2015-01 ,pp. : 386-388

Spandidos Publications

Access to resources Recommend Favorite

Hand-foot syndrome in a patient with metastatic lung adenocarcinoma induced by high-dose icotinib: A case report and review of the literature

By Zheng Yulong   Fang Weijia   Xu Nong  

Oncology Letters, Vol. 4, Iss. 6, 2012-12 ,pp. : 1341-1343

Spandidos Publications

Access to resources Recommend Favorite

Rechallenge with gefitinib following severe druginduced hepatotoxicity in a patient with advanced nonsmall cell lung cancer: A case report and literature review

By              

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 878-880

Spandidos Publications

Access to resources Recommend Favorite

Isolated spleen recurrence in a patient with lung adenocarcinoma: A case report

By            

Experimental and Therapeutic Medicine, Vol. 10, Iss. 2, 2015-01 ,pp. : 733-736

Spandidos Publications

Access to resources Recommend Favorite